Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11033-020-05479-3 http://scihub22266oqcxt.onion/10.1007/s11033-020-05479-3 32388698!7210797!32388698     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32388698.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Mol+Biol+Rep 2020 ; 47 (6): 4857-4860 Nephropedia Template TP {{tp|p=32388698|t=2020. BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic |pdf=|usr=}}{{32388698}} gab.com Text BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic JO: Mol Biol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32388698 #FOAvip The first person-to-person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia. Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency. In this context, our laboratory (Molecular and Genomic Diagnostics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS) re-modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered "urgent" and not postponable. In particular, this paper details changes regarding the execution of germline BRCA (gBRCA) testing in our laboratory. A substantial reduction in gBRCA testing (about 60%) compared to the first 2 months of the current year was registered, but the requests have not been reset. The requesting physicians were mainly gynaecologists and oncologists. These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing/Next Generation Sequencing (NGS) into clinical oncology. Finally, a re-organization of gBRCA testing in our Unit, mainly related to delayed and reduced arrival of tests was necessary, ensuring, however, a high-quality standard and reliability, mandatory for gBRCA testing in a clinical setting. Twit Text FOAVip BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic ????Mol Biol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32388698 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32388698 #FOAvip English Wikipedia <ref>{{Cite pmid|32388698}}</ref> BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic #MMPMID32388698 Minucci A; Scambia G; Santonocito C; Concolino P; Urbani A Mol Biol Rep 2020[Jun]; 47 (6): 4857-4860 PMID32388698show ga The first person-to-person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia. Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency. In this context, our laboratory (Molecular and Genomic Diagnostics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS) re-modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered "urgent" and not postponable. In particular, this paper details changes regarding the execution of germline BRCA (gBRCA) testing in our laboratory. A substantial reduction in gBRCA testing (about 60%) compared to the first 2 months of the current year was registered, but the requests have not been reset. The requesting physicians were mainly gynaecologists and oncologists. These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing/Next Generation Sequencing (NGS) into clinical oncology. Finally, a re-organization of gBRCA testing in our Unit, mainly related to delayed and reduced arrival of tests was necessary, ensuring, however, a high-quality standard and reliability, mandatory for gBRCA testing in a clinical setting. |*Pandemics[MESH] |BRCA2 Protein/*genetics[MESH] |Betacoronavirus/genetics/pathogenicity[MESH] |Biomarkers, Tumor/genetics[MESH] |Breast Neoplasms/*diagnosis/genetics/pathology[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques/statistics & numerical data[MESH] |Coronavirus Infections/blood/diagnosis/*epidemiology/pathology[MESH] |Early Detection of Cancer/methods/*statistics & numerical data[MESH] |Early Diagnosis[MESH] |Female[MESH] |Genomics/methods[MESH] |High-Throughput Nucleotide Sequencing/statistics & numerical data[MESH] |Humans[MESH] |Italy/epidemiology[MESH] |Mutation[MESH] |Ovarian Neoplasms/*diagnosis/genetics/pathology[MESH] |Pneumonia, Viral/blood/diagnosis/*epidemiology/pathology[MESH] |Referral and Consultation/statistics & numerical data[MESH]BRCA testing in a genomic diagnostics referral center during the COVID(epmc).pdf DeepDyve Pubget Overpricing